Axcella Health Inc. (AXLA): Price and Financial Metrics

Axcella Health Inc. (AXLA): $0.40

0.04 (-8.89%)

POWR Rating

Component Grades








Add AXLA to Watchlist
Sign Up

Industry: Biotech




#295 of 341

in industry

AXLA Price/Volume Stats

Current price $0.40 52-week high $41.25
Prev. close $0.44 52-week low $0.34
Day low $0.36 Volume 6,700
Day high $0.51 Avg. volume 267,009
50-day MA $3.38 Dividend yield N/A
200-day MA $7.54 Market Cap 1.18M

AXLA Stock Price Chart Interactive Chart >

Axcella Health Inc. (AXLA) Company Bio

Axcella Health Inc., a biotechnology company, researches and develops novel multifactorial interventions to support health and address dysregulated metabolism in the United States. The company develops its products based on its AXA Development Platform. It offers AXA1665 for use in treating hepatic encephalopathy; AXA1125 and AXA1957 to treat non-alcoholic fatty liver disease; AXA2678 for use in treating immobilization-induced acute muscle atrophy; and AXA4010 to target multiple biological pathways.

AXLA Latest News Stream

Event/Time News Detail
Loading, please wait...

AXLA Latest Social Stream

Loading social stream, please wait...

View Full AXLA Social Stream

Latest AXLA News From Around the Web

Below are the latest news stories about AXCELLA HEALTH INC that investors may wish to consider to help them evaluate AXLA as an investment opportunity.

12 Best Stocks For Day Trading

In this piece, we will take a look at the 12 Best Stocks For Day Trading. If you want to skip our introduction to trading indicators and the economic climate, then check out 5 Best Stocks For Day Trading. The modern day stock market is significantly different from the one of the early 1900s. These […]

Yahoo | October 30, 2023

3 Pharma Stocks to Dump Before the Damage Is Done

There's never a shortage of pharma stocks to sell due to the nature of the sector, especially when compounded by current fears.

Alex Sirois on InvestorPlace | October 8, 2023

Beware! 3 Biotech Stocks Waving Massive Red Flags Right Now

There are always many biotech stocks to avoid and these firms are among the clearest choices currently to steer clear of.

Alex Sirois on InvestorPlace | September 20, 2023

NKLA Stock Alert: Nikola Announces Canadian Expansion of Dealer Network

Nikola (NKLA) stock is a hot topic among traders on Friday as they go over the details of a new dealership expansion in Canada.

William White on InvestorPlace | September 15, 2023

NVS Stock Alert: Novartis Shareholders Approve Sandoz Spinoff

Novartis (NVS) stock is rising higher on Friday after the company announced approval for the spinoff of its generic drugs business Sandoz.

William White on InvestorPlace | September 15, 2023

Read More 'AXLA' Stories Here

AXLA Price Returns

1-mo N/A
3-mo N/A
6-mo -94.49%
1-year -95.99%
3-year -99.63%
5-year N/A
YTD -0.22%
2023 -95.10%
2022 -84.33%
2021 -59.73%
2020 29.43%
2019 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!